The principal component of amyloid plaques in Alzheimer disease is .3-amyloid protein, an -4-kDa peptide derived from amyloid precursor proteins. Previous studies have established that amyloid precursor proteins are secreted after proteolytic cleavage within the (3-amyloid peptide. The present investigation documents that, in cultured cells, amyloid precursor protein is cleaved on the plasma membrane by a membrane-bound endoprotease and that the specificity of peptide bond hydrolysis is largely independent of the primary sequence of the precursor. The principal determinants of cleavage appear to be an a-helical conformation and the distance (12-13 residues) of the hydrolyzed bond from membrane.
43-residue AP peptide is composed of 28 residues of the extracellular domain and 11-15 residues of the adjacent transmembrane domain of APP. Biochemical studies in cultured cells reveal that APPs mature rapidly through a constitutive secretory pathway and acquire N-and O-linked carbohydrates and tyrosine sulfate and phosphate during transit (14, 15) . In addition, C-terminally truncated APP derivatives are secreted into the conditioned medium (14) . The presence of C-terminally truncated APPs in the cerebrospinal fluid indicates that similar pathways may be used in vivo (14, 16) . In previous efforts, we used molecular biological approaches to demonstrate that APPs were cleaved within the AP domain (17) . Biochemical analysis of termini of membrane-retained and secreted molecules revealed that, in cultured mammalian cells, APP is cleaved between residues 16 (lysine) and 17 (leucine) of the AP3 sequence (18) (19) (20) . In concert, these studies indicated that AP3 cannot be generated as an intact fragment as a result of this proteolytic event but, rather, is derived by an alternative processing pathway(s) of APP.
In the present analysis, the cellular site(s) of APP cleavage and the structural specificities of the protease that liberate soluble APP derivatives are examined. This study documents that APP is a substrate when bound to the external side of the plasma membrane. The proteolytic activity exhibits a relaxed sequence specificity; membrane-bound precursors harboring widely differing primary sequences at or neighboring the cleavage site are cleaved efficiently. Amid the apparent lack of sequence specificity, the primary determinants for proteolysis appear to be an a-helical conformation and the distance (12-13 amino acids) of the hydrolyzed bond from the membrane.
MATERIALS AND METHODS
Transfection, Cell Labeling, Immunoprecipitation, and Immunoblotting. Details of these methods have been described (17 (14) .
Plasmid Constructions. p770SP, p7706M, and p77011M. Plasmids p7706M and p77011M were constructed essentially as described for the construction of p770SP (17) . Briefly, exonuclease III was used to generate 3' deletions of the APP-770 cDNA that resulted in truncations of C-terminal regions of the encoded polypeptide. Truncated cDNA was fused to a vector fragment encoding substance P to create p7706M and p77011M, which encoded the entire APP-770 extracellular domain and either 6 or 11 residues of the transmembrane helix, respectively. The sequence at the fusion site was verified by double-stranded sequencing of plasmid templates (22) .
p770DXB. p770 was digested with Xho I and Bgl II, and the ends were filled with Klenow DNA polymerase and deoxynucleotide triphosphates. The large (-5 kilobases) vector fragment was gel isolated and self-ligated to create p770DXB, which encodes an in-frame fusion between residues 380 and 665 of APP-770.
Mutagenesis. For generation of mutations at Lys-13, Leu-12, Val-11, or Phe-10, plasmid p770 (17) was incubated in PCR with "antisense" primer as2, CCGCTCGAGCTGTT-TCTTCTTCAGCATC, complementary to the sequence encoding four residues of the APP cytoplasmic domain and adjacent transmembrane regions, and either of the following oligonucleotides: s30, CCGCTCGAGGGATATGAAGT-TCATCATCAAVVVTTGGTGTTCT (V = A, G, or C), which encodes APP-770 residues 679-690 and is multiply degenerate at codon 687 (Lys-13); s32, CCGCTCGAGG-GATATGAAGTTCATCATCAAAAAVVVGTGTTCTTT-GC, which encodes APP-770 residues 679-692 and is multiply degenerate at codon 688 (Leu-12); s32, CCGCTCGAGG-GATATGAAGTTCATCATCAAAAATTGVVVTTCTT-TGCAGAAGATG, which encodes APP-770 residues 679-694 and is multiply degenerate at codon 689 (Val-li); or s33, CCGCTCGAGGGATATGAAGTTCATCATCAAAAAT-TGGTGVVVTTTGCAGAAGATG, which encodes APP-770 residues 679-694 and is multiply degenerate at codon 690 (Phe-10), respectively. For synthesis of p770A15 and p770A15+i, plasmid p770 and antisense primer as2 (see above) were incubated in a PCR with either s34, CCGCTC-GAGCATCAAAAATTGGTGTTCTTTGCAG, which encodes APP-770 residues 685-692; or s35, CCGCTCGAG-CATCATCAAAAATTGGTGTTCTTTGTTACCAACG-CAGAAGATG, which encodes APP-770 residues 685-695 and includes an insertion, Val-Thr-Asp. PCR products were digested with Xho I, purified by PAGE, and ligated to Xho I-digested and alkaline phosphatase-treated plasmid p770A (17) . The sequence of inserted fragments was verified by double-stranded sequencing of plasmid templates (22 
RESULTS
Membrane Association of APP Is Required for Cleavage. To address whether association with the plasma membrane is obligatory for APP cleavage, the fate of APP-770-related polypeptides containing deletions of the entire cytoplasmic region and segments of the transmembrane domain was analyzed. COS-1 cells were transfected with genes encoding APP-770 in which the last 56 (p77011M) or 61 (p7706M) amino acids of APP (including 13 or 18 amino acids of the transmembrane domain, respectively) and the entire cytoplasmic domain were replaced with a 16-amino acid epitope tag that contains the C terminus of neuropeptide substance P (23) (Fig. 1A) . Hybrid 77011M and 7706M molecules were expected to mature through the secretory pathway as soluble (nonmembrane associated) polypeptides because the residual transmembrane sequences from APP-770 are too short to span the lipid bilayer and to serve as a membrane anchor. After biosynthetic labeling, both 7706M and 77011M polypeptides migrated at -105 kDa, a position appropriate for the N-glycosylated precursor, and larger species of 115-135 kDa (Fig. 1B, lanes 1 and 2) . As expected, the conditioned medium contained 77011M-and 7706M-related molecules of =135 kDa (lanes 4 and 5). Immunoblot analysis of conditioned medium with a monoclonal antibody that recognizes an epitope at the C terminus of substance P revealed retention of substance P epitopes in secreted forms of 7706M and 77011M and proved that these polypeptides are not cleaved (Fig. 1C, lanes 1 and 2) . A parallel analysis of conditioned medium from CHO cells stably transfected with p7706M also revealed that secreted 7706M molecules are full length (Fig.  1D, lane 4) , whereas membrane-anchored substrates-i.e., 770SP (Fig. 1A) -in which the C-terminal 17 amino acids of APP are replaced with substance P sequences are cleaved efficiently (Fig. 1D, lane 3) . These studies strongly suggest that APPs are cleaved only as a membrane-bound substrate by one or more membrane-associated proteases.
APP Is Cleaved on the Plasma Membrane. Earlier studies in cultured cells documented the presence of full-length APP on the plasma membrane (14) . Accordingly, the fate of APP molecules still bound to the plasma membrane was addressed. For this analysis, CHO cells were stably transfected with p770DXB, a plasmid that encodes APP-770 deleted of 285 residues of the extracellular domain but retains the entire cytoplasmic and transmembrane regions and adjacent 35 amino acids of the extracellular domain ( Fig. 2A) at 40C, a temperature at which endocytosis is inhibited. This reaction resulted in labeling of an =85-kDa 770DXB polypeptide (Fig. 2C, lane 1) that migrates indistinguishably from the 0-glycosylated 770DXB polypeptide seen after [35S]methionine labeling (Fig. 2B, lane 1) . However, upon return to 37°C, the -85-kDa cell-surface species is metabolized rapidly (til2, 5 min) (Fig. 2C, lanes 2-5) , yielding a secreted species of -70 kDa (lanes 6-10).
In preliminary studies, it was also demonstrated that APPs that lack the hexapeptide sequence YENPTY, which resembles a clathrin-coated pit targeting signal, are secreted at higher rates than unmodified APPs (unpublished observations). This result is consistent with earlier reports documenting that a fraction of APP is degraded in cultured cells by lysosomal pathways (24, 25) . These results strongly suggest that APPs lacking an endocytic signal are retained on the plasma membrane for extended periods, thus increasing the probability of an endoproteolytic event. In concert, these findings reinforce the idea that cleavage at the plasma membrane is the preponderant pathway for generation of soluble APP derivatives in cultured cells.
Precursors with Substitutions at Lys-13 Are Cleaved Efficiently. To assess the specificity of the protease(s) involved in APP cleavage, secretion of APP harboring amino acid replacements of the lysine residue positioned at the N-terminal side of the cleavage site (13 amino acids N-terminal to the transmembrane domain) was examined. These substitutions were introduced into plasmid p770A20 (Fig. 3A) (17) . COS-1 cells were transfected transiently with wild-type or modified p770A20 templates and metabolically labeled; cleavage efficiency was assayed by the level of secreted molecules that accumulated in the conditioned medium. Most amino acid replacements (i.e., seven of eight) yielded precursors that were still cleaved efficiently (Fig. 3B, lanes 3 kDa). For only one mutant, 770A20K/V (corresponding to 770A20 containing a lysine-to-valine substitution), was secretion of APP-related molecules inefficient (Fig. 3B, lane 5) . To address whether the failure of 770AK/V molecules to be secreted was the result of inefficient maturation and/or sorting to the plasma membrane, two additional experiments were performed. First, because the abundance of newly synthesized intracellular pools of '110-kDa immature forms and -135-kDa 0-glycosylated forms of the mutant 770A20K/V (Fig. 3C, lane 2) and wild-type 770A20 polypeptides (lane 1) appeared indistinguishable, it is unlikely that low-level secretion of 770A20K/V precursors was a consequence of altered kinetics of intracellular maturation. To establish whether fully glycosylated forms of 770A20K/V molecules appeared on the plasma membrane, a CHO cell line that constitutively expresses 770A20K/V polypeptides was constructed, and cell surface molecules were crosslinked with a membrane impermeable crosslinker (BS3). Because only the mature (-135 kDa) forms of 770A20K/V molecules were selectively crosslinked to cell-surface polypeptides (Fig. 3D, lane 2 studies (17), we documented that APPs analogous to 770A20 described above but that lacked residues positioned between 6 and 11 amino acids N-terminal to the membrane were not cleaved. Interestingly, recent two-dimensional nuclear magnetic resonance studies of synthetic peptides containing this region revealed that these residues lie within an a-helix (26) . To test whether this putative helix is required for cleavage, 19 precursors containing single amino acid substitutions within this domain were examined (Fig. 4) . These substitutions were introduced into plasmid p770A20 (17) . Within this series of mutations, the only two precursors that exhibited significantly diminished cleavage efficiencies were those with amino acid substitutions that interrupted or distorted the predicted a-helix [e.g., a proline substitution in 770A20F/P (Fig. 4C, lane 4) or introduction of a glycine in 770A20V/G (Fig. 4B, lane 2) ]. These studies support the idea that local a-helicity contributes to cleavage efficiency, presumably through direct interaction of the endoprotease(s) to this structure.
Proteolytic Cleavage Occurs at a Defined Distance from the Transmembrane Helix. A curious feature of the soluble derivatives generated from mutant precursors cleaved at high, low, or moderate efficiencies is their indistinguishable electrophoretic migration (Figs. 3B and 4) . The complete absence of soluble derivatives with migration patterns different from those of the wild type strongly suggests that the protease(s) is constrained to cleave substrates at a specified distance from the membrane. If this interpretation is correct, then the migration of secreted APP-related polypeptides derived from plasmids analogous to p770A20 (see above), but that encoded either 24 (p770A24) or 15 (p770A15) amino acids of the APP extracellular domain, should yield larger or smaller cleavage products, respectively. Relative to the a70-kDa secreted form of 770A20 (Fig. 5B, lane 2 retarded or increased migration, respectively. For this to be the case, cleavage must occur at a single site (presumably between Lys-13 and Leu-12). More significantly, the insertion of an additional three residues (Val-Thr-Asp) between the normal cleavage site and the membrane (i.e., between Phe-9 and Ala-8) in p770A15+i yielded a product with a retarded migration relative to that of 770A15 (lane 4); this difference in migration can only be explained by cleavage occurring not at the original site (between Lys-13 and Leu-12) but, rather, at a more C-terminal site that lies the same number of amide bonds from the membrane-i.e., between adjacent phenylalanine residues. Although these electrophoretic approaches do not allow precise determination of the site of peptide bond hydrolysis, the results are consistent with a model in which the endopeptidase hydrolyzes a peptide bond positioned a particular number of residues from the membrane.
DISCUSSION
The principal component of amyloid plaques in Alzheimer disease is Af3, a 39-to 43-residue peptide derived from APP.
Af3 encompasses 28 residues of the extracellular and 11-15 residues of the transmembrane domain of APP. In cultured cells, APPs mature through the constitutive secretory pathway, and C-terminally truncated derivatives appear in the conditioned medium. Several groups (17) (18) (19) (20) have documented that, in cultured cells, secretion of the APP extracellular domain is the result of a specific proteolytic cleavage event between the 12th and 13th residues N-terminal to the APP transmembrane domain. These studies indicate that constitutive cleavage precludes the formation of the amyloidogenic 13-peptide. Recent studies by Pasternack et al. (27) confirm that secreted APP derivatives in human cerebrospinal fluid are likely derived by cleavage of APP at, or immediately adjacent to, the site used in vitro. To these reports, the present investigation provides two additional insights. First, (28) that suggests that the APPsecreting enzyme is not sequence specific. In any event, the specificity of peptide bond hydrolysis appears to occur within an a-helical domain, and cleavage occurs at a defined number of residues from the transmembrane helix. Although the present investigation provides important insights into the mechanism of constitutive cleavage of APP, it should be emphasized that the protease(s) involved in the constitutive cleavage of APP and the enzyme(s) responsible for the generation of Aj3 in the brain parenchyma of patients with Alzheimer disease have not been identified. In vivo studies indicate that neuronally synthesized APPs are axonally transported to synaptic terminals as full-length molecules, and, at these sites, APPs are cleaved (29) . Furthermore, immunocytochemical studies in nonhuman primates of advanced age (30) and in cases of Alzheimer disease (31) show accumulations of APP in enlarged neurites in proximity to deposits of A,3. Furthermore, ultrastructural analysis of "diffuse" plaques reveals B-amyloid accumulations in the neuropil that decorate dendritic arbors (32) . The present study shows obligatory linkage between the membrane association of APP and cleavage. In concert with immunocytochemical and ultrastructural studies in Alzheimer disease, we suggest that changes in the biology of membranes at nerve terminals and/or neurites result in alterations of the constitutive processingf of APPs that, ultimately, favor aberrant proteolytic events to be responsible for the generation of AP3.
